The Employment of Leukotriene Antagonists in Cutaneous Diseases Belonging to Allergological Field (Q34141112)

31 July 2017

2 references

17 November 2019

26 January 2021

The employment of leukotriene antagonists in cutaneous diseases belonging to allergological field (English)

1 reference

31 July 2017

The Employment of Leukotriene Antagonists in Cutaneous Diseases Belonging to Allergological Field (English)

1 reference

24 July 2024

1 reference

17 November 2019

leukotriene antagonists

2 references

17 November 2019

26 January 2021

1 reference

17 November 2019

5

Vincenzo Montinaro

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20886028

24 July 2024

author name string

Eustachio Nettis

1

1 reference

31 July 2017

Maddalena D'Erasmo

2

1 reference

31 July 2017

Elisabetta Di Leo

3

1 reference

31 July 2017

Gianfranco Calogiuri

4

1 reference

31 July 2017

Antonio Ferrannini

6

1 reference

31 July 2017

Angelo Vacca

7

1 reference

31 July 2017

language of work or name

1 reference

22 September 2010

4 references

full work available at URL

31 July 2017

17 June 2019

17 November 2019

26 January 2021

https://downloads.hindawi.com/journals/mi/2010/628171.pdf

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20886028

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20886028/pdf/?tool=EBI

24 July 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20886028

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20886028/?tool=EBI

24 July 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20886028

https://europepmc.org/articles/PMC2945673

24 July 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20886028

https://europepmc.org/articles/PMC2945673?pdf=render

24 July 2024

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20886028

http://downloads.hindawi.com/journals/mi/2010/628171.pdf

24 July 2024

1 reference

http://downloads.hindawi.com/journals/mi/2010/628171.xml

24 July 2024

1 reference

Mediators of Inflammation

24 July 2024

published in

4 references

31 July 2017

17 June 2019

17 November 2019

26 January 2021

2010

1 reference

Creative Commons Attribution 3.0 Unported

31 July 2017

copyright license

3 references

17 June 2019

17 November 2019

on focus list of Wikimedia project

26 January 2021

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945673

EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945673

Antiinflammatory effects of H1-antihistamines: clinical and immunological relevance.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945673

Cysteinyl-leukotriene receptor antagonists: present situation and future opportunities

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945673

Successful treatment of severe atopic dermatitis with cysteinyl leukotriene receptor antagonist montelukast

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945673

Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945673

The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945673

Clinical practice. Chronic urticaria and angioedema

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945673

Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945673

Leukotriene receptor antagonists--a novel therapeutic approach in atopic dermatitis?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945673

Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945673

Desloratadine: A new, nonsedating, oral antihistamine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945673

Leukotriene receptor antagonists may prevent NSAID-induced exacerbations in patients with chronic urticaria

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945673

Inhibition of cytokine secretion from human leukemic mast cells and basophils by H1- and H2-receptor antagonists

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945673

Chronic urticaria serum induces histamine release, leukotriene production, and basophil CD63 surface expression--inhibitory effects ofanti-inflammatory drugs

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945673

A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945673

Leukotriene modifiers in chronic urticaria

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945673

Enhanced releasability of prostaglandin E2 and leukotrienes B4 and C4 from leukocytes of patients with atopic eczema

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945673

Stress, symmetry, and psoriasis: possible role of neuropeptides.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945673

Accumulation of leukotriene C4 and histamine in human allergic skin reactions

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945673

Mast cells and their role in urticaria

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945673

Severe chronic urticaria is associated with elevated plasma levels of D-dimer

5 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F628171

Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F628171

The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F628171

Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F628171

The effectiveness of montelukast for the treatment of anti-histamine-resistant chronic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F628171

Leukotriene receptor antagonists in chronic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F628171

Zafirlukast has no beneficial effects in the treatment of chronic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F628171

Efficacy of montelukast, in combination with loratadine, in the treatment of delayed pressure urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F628171

Coagulation cascade and fibrinolysis in patients with multiple-drug allergy syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F628171

Oral monteleukast in urticaria induced by nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F628171

Pretreatment with montelukast blocks NSAID-induced urticaria and angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F628171

Efficacy and tolerability of montelukast as a therapeutic agent for severe atopic dermatitis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F628171

The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F628171

Montelukast in the treatment of children with moderate-to-severe atopic dermatitis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F628171

A double-blind, placebo-controlled trial of montelukast in adult atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F628171

Leukotriene receptor antagonists are ineffective for severe atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F628171

A randomized trial of leukotriene receptor antagonist montelukast in moderate-to-severe atopic dermatitis of adults.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945673

Comparison of montelukast and fexofenadine for chronic idiopathic urticaria.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945673

Contact allergic dermatitis and life-threatening anaphylaxis to chlorhexidine

28 October 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F628171

Human epidermis transforms exogenous leukotriene A4 into peptide leukotrienes: possible role in transcellular metabolism

21 January 2018

1 reference

12 December 2020

Antileukotrienes in chronic urticaria

1 reference

12 December 2020

Aspirin-sensitive urticaria: provocation with a leukotriene receptor antagonist

1 reference

12 December 2020

The leukotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis

1 reference

12 December 2020

Successful treatment of chronic urticaria with leukotriene antagonists

1 reference

12 December 2020

Increased levels of urinary leukotriene E4 in children with severe atopic eczema/dermatitis syndrome

1 reference

12 December 2020

Oral montelukast monotherapy is ineffective in chronic idiopathic urticaria: a comparison with oral cetirizine

1 reference

12 December 2020

Desloratadine in combination with montelukast suppresses the dermographometer challenge test papule, and is effective in the treatment of delayed pressure urticaria: a randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

Successful treatment of delayed pressure urticaria with montelukast

1 reference

12 December 2020

Improvement of cold urticaria by treatment with the leukotriene receptor antagonist montelukast

1 reference

12 December 2020

Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin

1 reference

12 December 2020

Skin responses to intradermal histamine and leukotrienes C4, D4, and E4 in patients with chronic idiopathic urticaria and in normal subjects

1 reference

12 December 2020

Acta Dermato-Venereologica

11

67

469

1987

1 reference

Association of chronic urticaria with thyroid autoimmunity and Raynaud phenomenon with anticentromere antibodies

24 July 2024

40

1 reference

Acta Dermatovenerologica Alpina, Panonica et Adriatica

24 July 2024

50

14

115

2005

1 reference

European Journal of Dermatology

24 July 2024

51

11

209

2001

1 reference

24 July 2024

Identifiers

DOI

10.1155/2010/628171

1 reference

31 July 2017

1 reference

31 July 2017

1 reference